Puk18 - Economic Evaluation of the Use of Sevelamer (Rifosar®) for the Treatment of Hyperphosphatemia in Patients With Chronic Renal Disease, From the Perspective of the Instituto Mexicano Del Seguro Social (Imss)

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2816
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Quality of Life in Pediatric Patients With Serous Otitis Media Using the OM6 Questionnaire, Centro Médico Nacional Del Noroeste, Instituto Mexicano Del Seguro Social Sonora, México

Scholarly Journal of Otolaryngology
2018English

Economic Impact of Floseal in Cardiac Surgery From the Perspective of the Mexican Institute of Social Security (IMSS)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Niveles De Plomo Sanguíneo en Madres Y Recién Nacidos Derechohabientes Del Instituto Mexicano Del Seguro Social

Salud Publica de Mexico
EnvironmentalPublic HealthOccupational Health
2000English

Erratum To: Sevelamer Is Cost Effective Versus Calcium Carbonate for the First-Line Treatment of Hyperphosphatemia in New Patients to Hemodialysis: A Patient-Level Economic Evaluation of the INDEPENDENT-HD Study

Journal of Nephrology
Nephrology
2014English

The Management of Hyperphosphatemia by Lanthanum Carbonate in Chronic Kidney Disease Patients

International Journal of Nephrology and Renovascular Disease
Nephrology
2012English

Prevalencia De Complicaciones De La Diabetes Y Comorbilidades Asociadas en Medicina Familiar Del Instituto Mexicano Del Seguro Social

Gaceta Medica de Mexico
Medicine
2018English

Puk19 - Cost-Utility of Sucroferric Oxyhydroxide for the Treatment of Hyperphosphatemia in Chronic Kidney Disease Patients Undergoing Dialysis in Canada

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Evaluation of the Preference, Satisfaction and Correct Use of Breezhaler® and Respimat® Inhalers in Patients With Chronic Obstructive Pulmonary Disease – INHALATOR Study

Respiratory Medicine
PulmonaryRespiratory Medicine
2018English

Switching From Allopurinol to Febuxostat for the Treatment of Hyperuricemia and Renal Function in Patients With Chronic Kidney Disease

Clinical Rheumatology
MedicineRheumatology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy